Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06655597 · ClinicalTrials.gov registry record · Phase 4
Efficacy of a Dietary Supplement Powder Formula (Daily Ultimate Essentials) in an Adult Population.
A Phase 4 study of Dietary Assessment, sponsored by Prenetics Global.
- Active
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06655597: Active Phase 4 study of Dietary Assessment, sponsored by Prenetics Global.
NCT06655597 is a Phase 4 study of Dietary Assessment that is active but no longer recruiting, run by Prenetics Global. The registered enrollment target is 60 participants, below the 103-participant average among 3 other Dietary Assessment trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06655597, a Phase 4 study of Dietary Assessment, is active but no longer recruiting, sponsored by Prenetics Global.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Healthy Adult subjects
Primary Outcome
Subjects assessed through weight and height which will be combined to determine BMI and abdominal and thigh circumference and images before and after
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT REDS Powder
Study Locations (1)
California
- San Francisco Research Institute - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2025-06 |
| Phase | Phase 4 |
What the registry record for NCT06655597 still lists
NCT06655597 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 103-participant average among 3 other Dietary Assessment trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Dietary Assessment appearing as the primary indexed condition, and to 1 intervention - of which REDS Powder is the first listed.
NCT06655597 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06655597 about?
NCT06655597 is a clinical study titled "Efficacy of a Dietary Supplement Powder Formula (Daily Ultimate Essentials) in an Adult Population.". Healthy Adult subjects
What is the current status of trial NCT06655597?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2024-10-01. Estimated completion is 2025-06.
What conditions does trial NCT06655597 study?
This clinical trial studies the following conditions: Dietary Assessment.
What interventions are being tested in trial NCT06655597?
The interventions under investigation include: REDS Powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06655597?
This trial is sponsored by Prenetics Global, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06655597 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dietary Assessment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI